Related Experiment Video
Updated: May 17, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2025 Trainee Symposium
M Elaine Husni1, Sibel Z Aydin2, Fabian Proft3
1M.E. Husni, MD, MPH, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
The Journal of Rheumatology
|May 15, 2026
Summary
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) meeting highlighted emerging research in psoriatic diseases. Trainee presentations showcased rigorous scientific work across basic, translational, and clinical domains.
Area of Science:
- Dermatology and Rheumatology research.
- Psoriatic disease investigation.
Background:
- The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) convenes annually.
- Psoriatic disease research requires continuous innovation and collaboration.
Purpose of the Study:
- To summarize research presented at the GRAPPA 2025 annual meeting.
- To highlight the work of emerging investigators in psoriatic diseases.
- To illustrate GRAPPA's role in advancing psoriatic disease understanding.
Main Methods:
- Review of 5 oral presentations.
- Summary of 17 poster presentations.
- Categorization of research into basic, translational, clinical, and outcomes.
Main Results:
- Presentations covered diverse aspects of psoriatic disease research.
- Emerging talent demonstrated scientific rigor.
- Research spanned multiple domains from basic science to clinical outcomes.
Conclusions:
- The GRAPPA 2025 meeting showcased a strong cohort of future researchers.
- The presented work contributes to advancing the understanding and management of psoriatic diseases.
- GRAPPA plays a key role in fostering global innovation in this field.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...